Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1/3 signaling
Abstract Background Hepatic ischemia reperfusion injury (HIRI) frequently gives rise to aggravated liver damage. Currently, there exists a diverse range of anesthetic drugs that possess protective capabilities against ischemia-reperfusion injury (IRI). Nevertheless, the specific functions and underl...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-04-01
|
| Seri Bilgileri: | BMC Gastroenterology |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12876-025-03820-3 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|